Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Cardiovascular Complications|Colorectal Cancer|Fallopian Tube Cancer|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Peritoneal Cavity Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: OTHER: laboratory biomarker analysis|OTHER: questionnaire administration
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)